Ignite Creation Date:
2024-05-06 @ 10:15 AM
Last Modification Date:
2024-10-26 @ 12:27 PM
Study NCT ID:
NCT03207009
Status:
COMPLETED
Last Update Posted:
2024-03-07
First Post:
2017-06-29
Brief Title:
A Study Evaluating the Efficacy and Safety of the LentiGlobin BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia
Sponsor:
bluebird bio
Organization:
bluebird bio
Organization Data
Organization:
bluebird bio
Class:
INDUSTRY
Study ID:
HGB-212
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
bluebird bio
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None